Carevive SMART Data – Refresher

Carevive’s digital oncology platform gathers crucial patient experience data, including symptoms, quality of life, social determinants of health, and functional status, directly from patients themselves.

This unique dataset empowers our life science partners to achieve three vital objectives.

Firstly, they can track longitudinal data over time, gaining deeper insights into patient experiences. Secondly, the data can be segmented by drug, biomarker, and patient demographics, enabling targeted analysis. Lastly, these invaluable insights drive enhanced patient adherence and pave the way for future drug development.

Recent Episodes

In this impactful episode of the ConCensis podcast, host Yasmeen Hassan sits down with Robby Miller, Sterile Processing Manager at St. Joseph’s Hospital Medical Center, to explore how artificial intelligence is revolutionizing the field of sterile processing. With nearly 30 years of experience in healthcare, Miller shares his journey from EMT to SPD leader, offering…

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

In an era where precision and predictability define the future of oncology, organoid technology is emerging as a transformative tool in drug discovery. These miniature, lab-grown 3D tissues mirror real human biology more closely than traditional 2D models or even animal systems, offering researchers the potential to predict patient-specific drug responses. As organoids become more…